|
Category: preservatives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 213.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 336.30 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.000044 mmHg @ 25.00 °C. (est) |
| Flash Point: | 292.00 °F. TCC ( 144.50 °C. ) (est)
|
| logP (o/w): | 2.061 (est) |
| Soluble in: |
| | water, 1.25E+05 mg/L @ 25 °C (exp) | | | water, 1e+006 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intravenous-dog LD50 562 mg/kg BEHAVIORAL: ANALGESIA Archives Internationales de Pharmacodynamie et de Therapie. Vol. 149, Pg. 571, 1964.
intraperitoneal-dog LDLo 990 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935.
oral-dog LDLo 450 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935.
intraperitoneal-guinea pig LDLo 900 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935.
oral-human LDLo 700 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA
BEHAVIORAL: EXCITEMENT
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) New England Journal of Medicine. Vol. 232, Pg. 617, 1945.
intramuscular-mouse LD50 760 mg/kg Acta Paediatrica Scandinavica. Vol. 59, Pg. 517, 1970.
intraperitoneal-mouse LD50 500 mg/kg Strahlentherapie. Vol. 127, Pg. 245, 1965.
intravenous-mouse LD50 500 mg/kg British Patent Document. Vol. #1009195
oral-mouse LD50 540 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 572, 1955.
intravenous-rabbit LD50 415 mg/kg Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 791, 1979.
oral-rabbit LD50 1700 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 89, Pg. 205, 1947.
intraperitoneal-rat LD50 542 mg/kg Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 791, 1979.
oral-rat LD50 930 mg/kg BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. Vol. 36(1-4), Pg. 10, 1989.
|
| Dermal Toxicity: |
subcutaneous-dog LDLo 200 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Revue Medicale de la Suisse Romande. Vol. 15, Pg. 561, 1895.
subcutaneous-frog LDLo 250 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935.
subcutaneous-guinea pig LDLo 800 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA
BEHAVIORAL: EXCITEMENT
CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) Revue Medicale de la Suisse Romande. Vol. 15, Pg. 561, 1895.
subcutaneous-mouse LD50 550 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 25, 1958.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | preservatives |
| Recommendation for sodium salicylate usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for sodium salicylate flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | alysine | | | ardall | | | aroall | | | benzoic acid, 2-hydroxy-, monosodium salt | | | benzoic acid, 2-hydroxy-, sodium salt (1:1) | | | camporisin | | | enterosalicyl | | | enterosalil | | | entrosalyl | | | glutosalyl | | 2- | hydroxybenzoic acid monosodium salt | | o- | hydroxybenzoic acid monosodium salt | | 2- | hydroxybenzoic acid sodium salt | | 2- | hydroxybenzoic acid, monosodium salt | | | idocyl novum | | | kerasalicyl | | | kerosal | | | magsalyl | | | nadisal | | | pabalate | | | parbocyl-rev | | neo- | salicyl | | | salicylic acid monosodium salt | | | salicylic acid sodium salt | | | salicylic acid, monosodium salt | | | salicylic acid, sodium salt | | | salisod | | | salsonin | | mono | sodium 2-hydroxybenzoate | | | sodium o-hydroxybenzoate | | | sodium ortho-hydroxybenzoate | | mono | sodium salicylate | | | sodium salicylate USP | | | sodium;2-hydroxybenzoate | | | sodiumsalicylate |
Articles:
|